Successful intervention for overwhelming postsplenectomy infection caused by non-vaccine pneumococcal serotype 23A.


Journal

Oxford medical case reports
ISSN: 2053-8855
Titre abrégé: Oxf Med Case Reports
Pays: England
ID NLM: 101642070

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 15 12 2019
revised: 27 02 2020
accepted: 05 03 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 13 5 2020
Statut: epublish

Résumé

The spleen plays an important role in the body's immune defense against invasive infections, particularly those caused by encapsulated bacteria. Encapsulated bacterial infection in asplenic patients is a medical emergency called overwhelming postsplenectomy infection (OPSI) and has a mortality rate of 50-70%. Here, we report the case of a 51-year-old Asian man who complained of emesis and diarrhea as primary symptoms. He rapidly progressed to coma and was eventually diagnosed with OPSI (pyogenic ventriculitis/spondylitis) caused by non-vaccine pneumococcal serotype 23A. Aggressive management, including empiric antibiotic therapy, a staircase approach for intracranial pressure-targeted therapy and laminectomy/laminoplasty, resulted in a good recovery. Our report highlights that non-vaccine pneumococcal serotypes can cause disease in vaccinated patients.

Identifiants

pubmed: 32395252
doi: 10.1093/omcr/omaa018
pii: omaa018
pmc: PMC7202049
doi:

Types de publication

Journal Article

Langues

eng

Pagination

omaa018

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

Oxf Med Case Reports. 2019 Jun 14;2019(6):omz044
pubmed: 31214357
N Engl J Med. 2002 Nov 14;347(20):1549-56
pubmed: 12432041
Crit Care Med. 1999 Apr;27(4):836-42
pubmed: 10321679
Lancet. 2011 Jul 2;378(9785):86-97
pubmed: 21474172
Neuroimaging Clin N Am. 2012 Nov;22(4):557-83
pubmed: 23122257
Lancet Infect Dis. 2018 Apr;18(4):441-451
pubmed: 29395999
Emerg Infect Dis. 2018 Nov;24(11):2010-2020
pubmed: 30334707
N Engl J Med. 2014 May 29;370(22):2121-30
pubmed: 24869722
BMC Infect Dis. 2016 Aug 09;16:392
pubmed: 27507415
CMAJ. 2017 Jun 12;189(23):E800-E802
pubmed: 28606976

Auteurs

Yuichi Kojima (Y)

Division of Internal Medicine, Department of Internal Medicine, Chitose City Hospital, Hokkaido 066-8550, Japan.

Kazuna Ikeda (K)

Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060-8543, Japan.

Akihiro Matsumura (A)

Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060-8543, Japan.

Shun Shimohama (S)

Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060-8543, Japan.

Bin Chang (B)

Department of Bacteriology 1, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.

Takayuki Yoshida (T)

Division of Internal Medicine, Department of Internal Medicine, Chitose City Hospital, Hokkaido 066-8550, Japan.

Kunio Hamada (K)

Division of Internal Medicine, Department of Internal Medicine, Chitose City Hospital, Hokkaido 066-8550, Japan.

Akihide Ito (A)

Division of Internal Medicine, Department of Internal Medicine, Chitose City Hospital, Hokkaido 066-8550, Japan.

Toshiki Ito (T)

Division of Internal Medicine, Department of Internal Medicine, Chitose City Hospital, Hokkaido 066-8550, Japan.

Classifications MeSH